TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33969554

Group type: EXPERIMENTAL
Intervention: C. mas extract (3 capsules of 300 mg per day for 8 weeks)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo (3 capsules of 300 mg starch powder per day for 8 weeks)
Number of subjects: 84
Study: 34176735

Group type: EXPERIMENTAL
Intervention: Mixed-mode survey (via email or letter with website)
Number of subjects: 239

Group type: COMPARATOR
Intervention: Paper survey (via mail)
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Mixed-mode survey
Number of subjects: 239

Group type: COMPARATOR
Intervention: Paper survey
Number of subjects: 239
Study: 34837999

Group type: EXPERIMENTAL
Intervention: Internet-based stress management training (iSMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: In-person group-based stress management training (gSMT)
Number of subjects: 0
Study: 34962055

Group type: EXPERIMENTAL
Intervention: Mindfulness-based mobile intervention (10-15 minutes per day for 8 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 64
Study: 32727162

Group type: EXPERIMENTAL
Intervention: 6 g/day Fish Oil (FO)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 32
Study: 34165818

Group type: EXPERIMENTAL
Intervention: FESCE-based early-mobility program
Number of subjects: 150

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Hyperinsulinemic euglycemic clamps
Number of subjects: 150
Study: 35130935

Group type: EXPERIMENTAL
Intervention: TtLIVE intervention (multi-component virtual care solution including virtual home visits, customizable care plans, clinical workflows, digitally secure communication, resource library)
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: TtLIVE intervention
Number of subjects: 440

Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 440
Study: 33744617

Group type: EXPERIMENTAL
Intervention: Reduced diet + 2,000 units of phytase (FYT)/kg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Reduced diet + 4,000 FYT/kg
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Reduced diet + 2,000 FYT/kg
Number of subjects: 320

Group type: COMPARATOR
Intervention: Basal diet without phytase
Number of subjects: 320

Group type: COMPARATOR
Intervention: Reduced diet without phytase
Number of subjects: 320
Study: 32147390

Group type: EXPERIMENTAL
Intervention: 7.5 × 10^6 DSC cells
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 1.5 × 10^6 DSC cells
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: 3.0 × 10^5 DSC cells
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 35983522

Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: CNN group
Number of subjects: 120
Study: 34506816

Group type: EXPERIMENTAL
Intervention: Health warnings (none, Canadian, or US warning)
Number of subjects: 45378

Group type: EXPERIMENTAL
Intervention: Full branding
Number of subjects: 45378

Group type: EXPERIMENTAL
Intervention: Plain packaging
Number of subjects: 45378

Group type: EXPERIMENTAL
Intervention: White background with no or limited branding
Number of subjects: 45378

Group type: EXPERIMENTAL
Intervention: Canadian health warnings
Number of subjects: 45378

Group type: EXPERIMENTAL
Intervention: US health warnings
Number of subjects: 45378

Group type: EXPERIMENTAL
Intervention: Plain packages
Number of subjects: 45378
Study: 32374229

Group type: EXPERIMENTAL
Intervention: Mini-open repair (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Percutaneous stabilization (Group B)
Number of subjects: 80
Study: 34049911

Group type: EXPERIMENTAL
Intervention: Conventional treatment plus calcium dobesilate (CaD) 500 mg three times per day for 12 months
Number of subjects: 1272

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 1272
Study: 36368947

Group type: EXPERIMENTAL
Intervention: Physical activity intervention including group sports activities, active guidance meetings, and a serious game to set physical activity goals.
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 100
Study: 33742792

Group type: EXPERIMENTAL
Intervention: Therapeutic touch (TT) as a complementary therapy
Number of subjects: 1302

Group type: COMPARATOR
Intervention: Therapeutic touch (TT)
Number of subjects: 1302
Study: 32192537

Group type: EXPERIMENTAL
Intervention: Exercise group (walking and lower limb strength training, 12 weeks low-intensity and 12 weeks high-intensity, 3 times/week)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (attention-matched, flexibility exercises and recreational activities)
Number of subjects: 91
Study: 35499504

Group type: EXPERIMENTAL
Intervention: JPFT in the morning (8:00 a.m)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Isometric chin-up test in the afternoon (5:00 p.m)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dynamic chin-up test in the afternoon (5:00 p.m)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dynamic test in the afternoon (5:00 p.m)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: TQR, well-being indices, and POMS
Number of subjects: 12
Study: 34897271

Group type: EXPERIMENTAL
Intervention: GH&W + face-to-face group activities (level 2)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: GH&W + individual support in medical checking (level 3)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Only GH&W (level 1)
Number of subjects: 335
Study: 35316556

Group type: EXPERIMENTAL
Intervention: Group 2 (probably in the subacromial bursa)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Group 3 (definitely in the subacromial bursa)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Group 1 (definitely/probably not in the subacromial bursa)
Number of subjects: 114
Study: 32357899

Group type: EXPERIMENTAL
Intervention: Shengjiang Xiexin decoction (SXD)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 33164608

Group type: EXPERIMENTAL
Intervention: Familiar audiobook narrator (Voice 1)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Unfamiliar audiobook narrator (Voice 2)
Number of subjects: 30
Study: 33158001

Group type: EXPERIMENTAL
Intervention: Modeling video intervention group (n=10)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Placebo video group (n=11)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (n=11)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: KOOS subscale scores
Number of subjects: 32
Study: 35038136

Group type: EXPERIMENTAL
Intervention: Ligation of intersphincteric fistula tract (LIFT)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Modified Parks technique
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Two-stage seton
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control group (not applicable)
Number of subjects: 66
Study: 33616605

Group type: EXPERIMENTAL
Intervention: Pediatric-onset multiple sclerosis (PoMS)
Number of subjects: 485

Group type: COMPARATOR
Intervention: Matched reference cohort without multiple sclerosis (MS)
Number of subjects: 485
Study: 32085537

Group type: EXPERIMENTAL
Intervention: ONS + DA
Number of subjects: 308

Group type: COMPARATOR
Intervention: DA
Number of subjects: 308
Study: 35674591

Group type: EXPERIMENTAL
Intervention: Continuous insulin infusion
Number of subjects: 42

Group type: COMPARATOR
Intervention: Bolus insulin
Number of subjects: 42
Study: 32674204

Group type: EXPERIMENTAL
Intervention: Lung ultrasound (LUS)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Chest X-ray (CXR)
Number of subjects: 45
Study: 36256987

Group type: EXPERIMENTAL
Intervention: Social-psychological intervention based on general withdrawal intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: General withdrawal intervention (Control)
Number of subjects: 100
Study: 33771496

Group type: EXPERIMENTAL
Intervention: 6-hour single-balloon catheter placement with oxytocin
Number of subjects: 178

Group type: COMPARATOR
Intervention: 12-hour single-balloon catheter placement with oxytocin
Number of subjects: 178
Study: 35910931

Group type: EXPERIMENTAL
Intervention: Culturally specific sexual and reproductive health curriculum in school
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Parental education to improve parent-child communication about SRH and healthy relationships
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cultural mentorship
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Improvement of delivery of SRH services from reservation healthcare agencies
Number of subjects: 0
Study: 32864805

Group type: EXPERIMENTAL
Intervention: Single-agent concurrent chemoradiotherapy using S-1
Number of subjects: 105

Group type: COMPARATOR
Intervention: Double-agent concurrent chemoradiotherapy using S-1 and cisplatin
Number of subjects: 105
Study: 35513772

Group type: EXPERIMENTAL
Intervention: Low-severity social exclusion condition
Number of subjects: 372

Group type: COMPARATOR
Intervention: High-severity social exclusion condition
Number of subjects: 372
Study: 33166437

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Exercise (MICE)
Number of subjects: 10
Study: 35279025

Group type: EXPERIMENTAL
Intervention: BOOST program (physical and psychological group intervention)
Number of subjects: 438

Group type: COMPARATOR
Intervention: Best practice advice (BPA)
Number of subjects: 438
Study: 34312902

Group type: EXPERIMENTAL
Intervention: Optimal design with unequal allocation of clusters and unequal cluster size
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Optimal design under constraints on the number of clusters or cluster size
Number of subjects: 0
Study: 35080029

Group type: EXPERIMENTAL
Intervention: Usual physiotherapy care interventions (including task specific training delivered at weekly intensity for 4-6 weeks)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Monitoring of children with Gross Motor Function Classification System level III on long-term pathways
Number of subjects: 12
Study: 33940892

Group type: EXPERIMENTAL
Intervention: Deep embedded clustering (DEC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Gaussian mixture models (GMM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional clustering
Number of subjects: 0
Study: 36001335

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 1660

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 1660
Study: 33707161

Group type: EXPERIMENTAL
Intervention: Convolutional neural networks (CNNs) using chest radiography
Number of subjects: 239
Study: 32840653

Group type: EXPERIMENTAL
Intervention: 13C‐TCA and 13C‐TCG in urine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Plasma concentrations
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unlabeled biomarker concentrations
Number of subjects: 0

Group type: COMPARATOR
Intervention: MTCA
Number of subjects: 0
Study: 35305231

Group type: EXPERIMENTAL
Intervention: WISE intervention (awareness-raising for staff, peer support service, MHFA training for teachers)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: WISE intervention components
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: WISE intervention
Number of subjects: 25
Study: 32341291

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 63

Group type: COMPARATOR
Intervention: Rest intervention
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: K-D test reliability
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: False-positive rate
Number of subjects: 63
Study: 36036977

Group type: EXPERIMENTAL
Intervention: Full-thickness skin microbiopsies harvested at diameters of 200, 400, 500, 600, 800 μm, 1, and 2 mm
Number of subjects: 8
Study: 33130147

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 476
Study: 32130090

Group type: EXPERIMENTAL
Intervention: NO3‐rich beetroot juice (BR; ∼ 9.2 mmol NO3‐)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 11
Study: 32629737

Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine (TCM) decoction for 4 weeks
Number of subjects: 150

Group type: COMPARATOR
Intervention: Celecoxib (specific daily dose)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: TCM decoction
Number of subjects: 150

Group type: COMPARATOR
Intervention: Celecoxib
Number of subjects: 150
Study: 35039203

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field therapy (PEMF) applied via a removable appliance worn for 8-10 hours during canine retraction.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control side with no PEMF exposure (obstructed by foil).
Number of subjects: 19
Study: 33151266

Group type: EXPERIMENTAL
Intervention: CTC-driven treatment choice (chemotherapy if ≥5 CTCs/7.5 mL; endocrine therapy if <5 CTCs/7.5 mL)
Number of subjects: 755

Group type: COMPARATOR
Intervention: Clinician-driven treatment choice (control arm)
Number of subjects: 755

Group type: EXPERIMENTAL
Intervention: CTC-driven treatment choice
Number of subjects: 755

Group type: COMPARATOR
Intervention: Clinician-driven treatment choice
Number of subjects: 755
Study: 32895015

Group type: EXPERIMENTAL
Intervention: Long sleep (≤9 hours per day)
Number of subjects: 79881

Group type: EXPERIMENTAL
Intervention: Short sleep (<7 hours per day)
Number of subjects: 79881

Group type: COMPARATOR
Intervention: Mendelian randomization analysis
Number of subjects: 79881
Study: 34788571

Group type: EXPERIMENTAL
Intervention: Golodirsen 30 mg/kg
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Golodirsen
Number of subjects: 23

Group type: COMPARATOR
Intervention: External controls
Number of subjects: 23
Study: 32621905

Group type: EXPERIMENTAL
Intervention: Motivational interviewing-enhanced integrated behavior therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Integrated behavior therapy (video-based behavioral weight loss program and problem-solving therapy for depression)
Number of subjects: 0
Study: 34204400

Group type: EXPERIMENTAL
Intervention: Whole Body Vibration (WBV)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Bicycle ergometer training
Number of subjects: 64

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 64
Study: 32084567

Group type: COMPARATOR
Intervention: Standard defibrillation
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Vector change defibrillation (VC)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Double sequential external defibrillation (DSED)
Number of subjects: 152
Study: 35610743

Group type: EXPERIMENTAL
Intervention: Perioperative Transfusion Trigger Score (POTTS) group
Number of subjects: 864

Group type: COMPARATOR
Intervention: Control group (based on 2012 AABB guideline)
Number of subjects: 864

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 864
Study: 33839429

Group type: EXPERIMENTAL
Intervention: Self-compression on the right breast
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard mammographic procedure (control group)
Number of subjects: 200
Study: 34863776

Group type: EXPERIMENTAL
Intervention: RLRL treatment plus single-vision spectacle (SVS)
Number of subjects: 264

Group type: COMPARATOR
Intervention: SVS
Number of subjects: 264

Group type: EXPERIMENTAL
Intervention: RLRL treatment
Number of subjects: 264
Study: 32820334

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 1205
Study: 36096283

Group type: EXPERIMENTAL
Intervention: Nalox‐Comm training module
Number of subjects: 60

Group type: COMPARATOR
Intervention: Basic online naloxone training module (control group)
Number of subjects: 60
Study: 33516047

Group type: EXPERIMENTAL
Intervention: Self-regulation intervention (n=72)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Usual care group (n=72)
Number of subjects: 144
Study: 32868821

Group type: EXPERIMENTAL
Intervention: Rainfall
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temperature
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Aerosol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Precipitation
Number of subjects: 0
Study: 33446635

Group type: EXPERIMENTAL
Intervention: 14:10 Time Restricted Eating (TRE)
Number of subjects: 78

Group type: COMPARATOR
Intervention: 12:12 Time Restricted Eating (TRE) (active comparator)
Number of subjects: 78
Study: 32886102

Group type: EXPERIMENTAL
Intervention: Multilevel surgery (modified uvulopalatopharyngoplasty and minimally invasive tongue volume reduction; n=51)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Ongoing medical management (eg, advice on sleep positioning, weight loss; n=51)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Multilevel surgery
Number of subjects: 102

Group type: COMPARATOR
Intervention: Ongoing medical management
Number of subjects: 102
Study: 35690262

Group type: EXPERIMENTAL
Intervention: SHARING Choices intervention
Number of subjects: 55

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 55
Study: 34642244

Group type: EXPERIMENTAL
Intervention: Discontinuing β‐lactam treatment after 3 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32202637

Group type: EXPERIMENTAL
Intervention: Acalabrutinib 100 mg twice daily (BID)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Acalabrutinib 200 mg once daily (QD)
Number of subjects: 48
Study: 35719236

Group type: EXPERIMENTAL
Intervention: Sand-based PJT combined with endurance running on outdoor surface (OT)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sand-based PJT combined with endurance running on treadmill surface (TT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 75
Study: 34023797

Group type: EXPERIMENTAL
Intervention: JNJ-39393406 (n=35)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Placebo (n=36)
Number of subjects: 71
Study: 35764522

Group type: EXPERIMENTAL
Intervention: Acupoint catgut embedding combined with quadruple therapy
Number of subjects: 139

Group type: COMPARATOR
Intervention: Oral Weifuchun Tablets with quadruple therapy
Number of subjects: 139
Study: 32388694

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch-up (ABC) intervention
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control participants received home-based EHS plus 10 weekly books
Number of subjects: 186
Study: 34563096

Group type: EXPERIMENTAL
Intervention: NUDT15 genotype-based dose optimisation (50% dose reduction for CT genotype, alternative drugs for TT genotype)
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: NUDT15 genotype-based dose optimisation (50% dose reduction for CT genotype)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Control group (standard dose for CC genotype)
Number of subjects: 118
Study: 36443615

Group type: EXPERIMENTAL
Intervention: SEIP IMN technique
Number of subjects: 88

Group type: COMPARATOR
Intervention: HFIP IMN technique
Number of subjects: 88
Study: 34530254

Group type: EXPERIMENTAL
Intervention: Rituximab-abbs
Number of subjects: 201

Group type: COMPARATOR
Intervention: Rituximab
Number of subjects: 201
Study: 35958282

Group type: EXPERIMENTAL
Intervention: Bone filling mesh container vertebroplasty
Number of subjects: 0

Group type: COMPARATOR
Intervention: Percutaneous kyphoplasty (PKP)
Number of subjects: 0
Study: 33653352

Group type: EXPERIMENTAL
Intervention: Dox@IR825@Gd@CDs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: NIR laser irradiation with Dox@IR825@Gd@CDs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rotarod test
Number of subjects: 0
Study: 36383383

Group type: EXPERIMENTAL
Intervention: Hydrocortisone group (intravenous and subsequent oral hydrocortisone, using a taper program)
Number of subjects: 436

Group type: COMPARATOR
Intervention: No-hydrocortisone group
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Hydrocortisone group
Number of subjects: 436
Study: 34460948

Group type: EXPERIMENTAL
Intervention: Dupilumab (300 mg weekly subcutaneous)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dupilumab (after 48 weeks of treatment)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dupilumab (in patients with baseline IgE ≥ 200 IU/ml)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Baseline IgE levels
Number of subjects: 60
Study: 33316582

Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy
Number of subjects: 349

Group type: COMPARATOR
Intervention: Conventional fractionated radiotherapy
Number of subjects: 349
Study: 32780023

Group type: EXPERIMENTAL
Intervention: 1-week electronic mindfulness-based intervention (eMBI)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 68
Study: 34231846

Group type: EXPERIMENTAL
Intervention: DADEE intervention (9-week program with weekly sessions plus home-based tasks)
Number of subjects: 344

Group type: COMPARATOR
Intervention: Waitlist-control group
Number of subjects: 344
Study: 34370656

Group type: EXPERIMENTAL
Intervention: Osteoprotegerin and sclerostin levels in postmenopausal women with osteoporosis
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (postmenopausal women without osteoporosis)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Other markers
Number of subjects: 40

Group type: COMPARATOR
Intervention: Correlation with BMD
Number of subjects: 40
Study: 32309876

Group type: EXPERIMENTAL
Intervention: Preemptive indwelling of double-J stents (PI-DJS)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Preemptive indwelling of ureteral catheters (PI-UC)
Number of subjects: 75
Study: 34537124

Group type: EXPERIMENTAL
Intervention: TAP block using 20-cc 0.5% bupivacaine solution
Number of subjects: 80

Group type: COMPARATOR
Intervention: p-TAP (placebo) using 20-cc isotonic solution
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: TAP block
Number of subjects: 80

Group type: COMPARATOR
Intervention: p-TAP (placebo)
Number of subjects: 80
Study: 32487210

Group type: EXPERIMENTAL
Intervention: Enteral Nutrition (EN)
Number of subjects: 321

Group type: COMPARATOR
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 321
Study: 35735195

Group type: EXPERIMENTAL
Intervention: Fusion imaging guidance (Vessel Navigator®, Philips)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control (no fusion imaging guidance)
Number of subjects: 64
Study: 34284344

Group type: EXPERIMENTAL
Intervention: DCVAC/LuCa and chemotherapy (carboplatin and paclitaxel)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: DCVAC/LuCa, chemotherapy, pegylated interferon‐?2b, and hydroxychloroquine
Number of subjects: 112

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 112